Darveau M - Search Results

1

Reticulocyte hemoglobin content in critically ill patients.

Darveau M, Lachance P. Darveau M, et al. Anesthesiology. 2010 Dec;113(6):1479. doi: 10.1097/ALN.0b013e3181f85eee. Anesthesiology. 2010. PMID: 21102191 Free article. No abstract available.

2

Bench-to-bedside review: iron metabolism in critically ill patients.

Darveau M, Denault AY, Blais N, Notebaert E. Darveau M, et al. Crit Care. 2004 Oct;8(5):356-62. doi: 10.1186/cc2862. Epub 2004 May 13. Crit Care. 2004. PMID: 15469598 Free PMC article. Review.

3

Recombinant human erythropoietin use in intensive care.

Darveau M, Notebaert E, Denault AY, Bélisle S. Darveau M, et al. Ann Pharmacother. 2002 Jun;36(6):1068-74. doi: 10.1345/aph.1A323. Ann Pharmacother. 2002. PMID: 12022910 Review.

4

Comment: use of epoetin alfa in critically ill patients.

Darveau M, Notebaert E. Darveau M, et al. Ann Pharmacother. 2004 Jul-Aug;38(7-8):1325-6. doi: 10.1345/aph.1D368a. Epub 2004 May 25. Ann Pharmacother. 2004. PMID: 15161948 No abstract available.

5

Reliability, validity and ease of use of a portable point-of-care coagulation device in a pharmacist-managed anticoagulation clinic.

Lizotte A, Quessy I, Vanier MC, Martineau J, Caron S, Darveau M, Dubé A, Gilbert E, Blais N, Lalonde L. Lizotte A, et al. Among authors: darveau m. J Thromb Thrombolysis. 2002 Dec;14(3):247-54. doi: 10.1023/a:1025061129122. J Thromb Thrombolysis. 2002. PMID: 12913406

6

Erythropoietic response to two epoetin alfa regimens in critically ill patients: a pilot study.

Darveau M, Notebaert E, Denault AY, Williamson DR, Albert M, Bélisle S, Lachaine J. Darveau M, et al. Pharmacotherapy. 2006 Nov;26(11):1587-94. doi: 10.1592/phco.26.11.1587. Pharmacotherapy. 2006. PMID: 17064203 Clinical Trial.

7

Nuclear Pharmacy Training in the Era of Theranostics: Toward Meeting the Needs of Nuclear Medicine Patients for Comprehensive Pharmaceutical Care.

Laverdière I, Matte G, Darveau M, Beauregard JM. Laverdière I, et al. Among authors: darveau m. J Nucl Med. 2024 Aug 1;65(8):1330-1331. doi: 10.2967/jnumed.124.267603. J Nucl Med. 2024. PMID: 38906559 No abstract available.

8

Trends and gaps in the use of citizen science derived data as input for species distribution models: A quantitative review.

Feldman MJ, Imbeau L, Marchand P, Mazerolle MJ, Darveau M, Fenton NJ. Feldman MJ, et al. Among authors: darveau m. PLoS One. 2021 Mar 11;16(3):e0234587. doi: 10.1371/journal.pone.0234587. eCollection 2021. PLoS One. 2021. PMID: 33705414 Free PMC article. Review.

9

Real-World Budget Impact of Listing a Biosimilar of Rituximab.

Boidart A, Darveau M, Déry N, Racine MC. Boidart A, et al. Among authors: darveau m. Can J Hosp Pharm. 2020 Jan-Feb;73(1):13-18. Epub 2020 Feb 1. Can J Hosp Pharm. 2020. PMID: 32109956 Free PMC article.

10

Treatment for calcium channel blocker poisoning: a systematic review.

St-Onge M, Dubé PA, Gosselin S, Guimont C, Godwin J, Archambault PM, Chauny JM, Frenette AJ, Darveau M, Le Sage N, Poitras J, Provencher J, Juurlink DN, Blais R. St-Onge M, et al. Among authors: darveau m. Clin Toxicol (Phila). 2014 Nov;52(9):926-44. doi: 10.3109/15563650.2014.965827. Epub 2014 Oct 6. Clin Toxicol (Phila). 2014. PMID: 25283255 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters